Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Louis-David Cantin is active.

Publication


Featured researches published by Louis-David Cantin.


Bioorganic & Medicinal Chemistry Letters | 2007

PDE-10A inhibitors as insulin secretagogues

Louis-David Cantin; Steven Magnuson; David E. Gunn; Nicole Barucci; Marina Breuhaus; William Bullock; Jennifer Burke; Thomas Claus; Michelle Daly; Lynn B. DeCarr; Ann Gore-Willse; Helana Hoover-Litty; Ellalahewage Kumarasinghe; Yaxin Li; Sidney X. Liang; James N. Livingston; Timothy B. Lowinger; Margit MacDougall; Herbert Ogutu; Alan Olague; Ronda Ott-Morgan; Robert W. Schoenleber; Adrian Tersteegen; Philip Wickens; Zhonghua Zhang; Jian Zhu; Lei Zhu; Laurel Sweet


Archive | 2003

Anilinopyrazole derivatives useful for the treatment of diabetes

Joachim Rudolph; Louis-David Cantin; Steven Magnuson; William Bullock; Ann-Marie Bullion; Libing Chen; Chih-Yuan Chuang; Sidney X. Liang; Dyuti Majumdar; Herbert Ogutu; Alan Olague; Ning Qi; Philip Wickens


Archive | 2003

Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics

Philip Wickens; Louis-David Cantin; Chih-Yuan Chuang; Miao Dai; Martin F. Hentemann; Ellalahewage Kumarasinghe; Sidney X. Liang; Derek Lowe; Tatiana Shelekhin; Yamin Wang; Chengzhi Zhang; Hai-Jun Zhang; Qian Zhao


Archive | 2003

Indane acetic acid derivatives and their use as pharmaceutical agents

Philip Wickens; Louis-David Cantin; Ellalahewage Kumarasinghe; Chih-Yuan Chuang; Sidney X. Liang


Bioorganic & Medicinal Chemistry Letters | 2007

Indanylacetic acids as PPAR-δ activator insulin sensitizers

Philip Wickens; Chengzhi Zhang; Xin Ma; Qian Zhao; John Amatruda; William Bullock; Michael Burns; Louis-David Cantin; Chih-Yuan Chuang; Thomas Claus; Miao Dai; Fernando E. Dela Cruz; David Dickson; Frederick J. Ehrgott; Dongping Fan; Sarah Heald; Martin F. Hentemann; Christiana Iwuagwu; Jeffrey S Johnson; Ellalahewage Kumarasinghe; David Ladner; Rico C. Lavoie; Sidney X. Liang; James N. Livingston; Derek Lowe; Steve Magnuson; Gretchen Mannelly; Ingo A. Mugge; Herbert Ogutu; ‡ Susan Pleasic-Williams


Archive | 2005

5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes

Louis-David Cantin; Xin Ma; Christiana Akuche; Sidney X. Liang


Archive | 2004

Indole acetic acid derivatives and their use as pharmaceutical agents

Xin Ma; Louis-David Cantin; Soongyu Choi; Roger Clark; Martin F. Hentemann; Joachim Rudolph; Rico C. Lavoie; Zhonghua Zhang


Bioorganic & Medicinal Chemistry Letters | 2007

Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

Louis-David Cantin; Sidney X. Liang; Herbert Ogutu; Christiana Iwuagwu; Ken Boakye; William Bullock; Michael Burns; Roger Clark; Thomas Claus; Fernando E. delaCruz; Michelle Daly; Frederick J. Ehrgott; Jeffrey S Johnson; Christine Keiper; James N. Livingston; Robert W. Schoenleber; Jeffrey Shapiro; Christopher Town; Ling Yang; Manami Tsutsumi; Xin Ma


Archive | 2006

Derives de pyrazolyluree utilisables dans le traitement du cancer

Louis-David Cantin; Roger A. Smith; Zhi Chen; Holia N. Hatoum-Mokdad; Eric S. Mull; Wendy Lee


Archive | 2006

Composes de l'uree utilises dans le traitement du cancer

Donald Bierer; Louis-David Cantin; Christopher A. Carter; Wenlang Fu; Richard Gedrich; Holia N. Hatoum-Mokdad; Gaetan Ladouceur; Dhanapalan Nagarathnam; Herbert Ogutu; Sanjeeva P. Reddy; Aaron Schmitt; Roger A. Smith; Ian Taylor; Yamin Wang; Scott Wilhelm; Xiaomei Zhang

Researchain Logo
Decentralizing Knowledge